EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

A scoping review of the acceptability, feasibility and effectiveness of opt‐out blood‐borne virus ( BBV ) testing in secondary healthcare settings, in the UK and similar settings, using APEASE criteria

Becky Metcalfe, Karen J Maxwell, Kirsten Trayner, Max Wilkinson, Sharon Hutchinson, Claudia Estcourt, Alison J Rodger iD

HIV Medicine · 2026

DOI: 10.1111/hiv.70284 ↗

Kurz gefasst

Scoping Review in der Zeitschrift HIV Medicine, 2026. Verfasst von Becky Metcalfe und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Health & Life Science, Glasgow Caledonian University, Glasgow, UK. Hauptthemen laut MEDLINE: Blood-Borne Infections, Blood-Borne Pathogens, Hepatitis C, HIV Infections. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scottish Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Earlier diagnosis of blood‐borne viruses (BBVs)—HIV, hepatitis B (HBV) and hepatitis C (HCV)—remains a significant public‐health focus. Opt‐out testing in secondary healthcare settings can improve early diagnosis and linkage to care as part of BBV transmission elimination targets. This scoping review used APEASE criteria (acceptability, practicability, effectiveness, affordability, side‐effects and equity) to evaluate opt‐out BBV testing interventions in emergency departments (EDs) and medical assessment units (MAUs).

Methods

A systematic search of three databases was conducted for peer‐reviewed literature up to 30th June 2025. Inclusion criteria were: (a) opt‐out BBV testing intervention; (b) taking place within a secondary care setting; and (c) in the UK, Ireland, Australia and Canada. Data were extracted and analysed using APEASE criteria.

Results

Twenty‐eight studies met inclusion criteria. Opt‐out testing was acceptable to patients and healthcare professionals, particularly when supported by clear communication, staff training and leadership engagement. Practicability varied by setting; barriers included time constraints, unclear responsibilities and logistical challenges. Automation using electronic systems facilitated implementation. Effectiveness was demonstrated through increased testing uptake and case identification, especially in EDs. Minimal evidence exists on affordability and is likely to vary by population prevalence. No significant side effects (unintended outcomes) were reported, and universal testing was associated with reduced stigma. Opt‐out testing can improve access to testing for underserved populations, supporting its role in promoting health equity.

Conclusion

Opt‐out BBV testing in secondary care settings (EDs and MAUs) is a feasible, effective and equitable intervention when supported by appropriate infrastructure and resources. Efforts should focus on optimizing implementation strategies and extending opt‐out testing, including to lower‐prevalence settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Borne InfectionsBlood-Borne PathogensHepatitis CHIV InfectionsMass ScreeningPatient Acceptance of Health CareHumansFeasibility StudiesSecondary Health CareUnited Kingdom

Stichwörter der Autor:innen

BBVHIVHepatitisopt‐out testing

Autor:innen und Institutionen

  • School of Health & Life Science, Glasgow Caledonian University, Glasgow, UK.
  • NHS Greater Glasgow & Clyde, Glasgow, UK.
  • Public Health Scotland, Edinburgh, UK.
  • University College London, London, UK.

ORCID-Profile: Alison J Rodger

Förderung

  • Scottish Government

Zitieren

APA

Metcalfe, B., Maxwell, K. J., Trayner, K., Wilkinson, M., Hutchinson, S., Estcourt, C., & Rodger, A. J. (2026). A scoping review of the acceptability, feasibility and effectiveness of opt‐out blood‐borne virus ( BBV ) testing in secondary healthcare settings, in the UK and similar settings, using APEASE criteria. HIV Medicine. https://doi.org/10.1111/hiv.70284

Vancouver

Metcalfe B, Maxwell KJ, Trayner K, Wilkinson M, Hutchinson S, Estcourt C, et al. A scoping review of the acceptability, feasibility and effectiveness of opt‐out blood‐borne virus ( BBV ) testing in secondary healthcare settings, in the UK and similar settings, using APEASE criteria. HIV Medicine. 2026. doi:10.1111/hiv.70284

BibTeX
@article{Metcalfe2026,
  author = {Metcalfe, Becky and Maxwell, Karen J and Trayner, Kirsten and Wilkinson, Max and Hutchinson, Sharon and Estcourt, Claudia and Rodger, Alison J},
  title = {A scoping review of the acceptability, feasibility and effectiveness of opt‐out blood‐borne virus ( BBV ) testing in secondary healthcare settings, in the UK and similar settings, using APEASE criteria},
  journal = {HIV Medicine},
  year = {2026},
  doi = {10.1111/hiv.70284}
}
Kostenlos starten →